Meropenem vs Cefotaxime as Empirical Treatment of SBP

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
We aimed to evaluate whether meropenem is superior to cefotaxime for treatment of SBP empirically.
Epistemonikos ID: e8f56d293fb02915d4ee185db24d4289ce23b84d
First added on: May 13, 2024